NCT00669734View on ClinicalTrials.gov

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 1, 2010

Primary Completion Date

September 2, 2021

Study Completion Date

April 23, 2026

Conditions
Locally Advanced Pancreatic AdenocarcinomaPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions
BIOLOGICAL

Falimarev

Given intratumorally or SC

BIOLOGICAL

Inalimarev

Given SC

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Sargramostim

Given SC

Trial Locations (1)

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH